GlassScriptPhysician profile
Rohit Panchal
NPI 1932178688
$5,672.57
in general payments reported to CMS, 2019-2025
42 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $579 · 2021: $445 · 2022: $741 · 2023: $681 · 2024: $1,029 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.94 |
| Education | $147.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $810.64 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Harmony Biosciences LLC | $553.51 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $487.67 | 2019-2025 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $472.54 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Grifols USA, LLC | $433.88 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $412.60 | 2019-2025 | Ofev |
| Jazz Pharmaceuticals INC. | $335.32 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $273.09 | 2019-2025 | Dupixent |
| Genzyme Corporation | $228.44 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $217.60 | 2020-2025 | Winrevair, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $185.44 | 2019-2022 | |
| Intuitive Surgical, INC. | $173.29 | 2022 | |
| United Therapeutics Corporation | $115.50 | 2019-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $99.45 | 2019-2024 | Yupelri |
| Insmed, INC. | $95.30 | 2020-2025 | Arikayce, Brinsupri |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $68.76 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 | |
| Abiomed | $51.29 | 2024 | Impella |
| Eisai INC. | $51.28 | 2020-2021 | |
| Inogen, INC. | $51.10 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Sunovion Pharmaceuticals INC. | $46.40 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $44.01 | 2019-2024 | Xarelto |
| Verona Pharma, INC. | $35.68 | 2025 | Ohtuvayre |
| Amgen INC. | $35.42 | 2022 | |
| Electromed, INC. | $31.69 | 2025 | Smartvest |
| Axsome Therapeutics, INC. | $24.64 | 2025 | Sunosi |
| Tactile Systems Technology INC | $24.61 | 2024 | Flexitouch Plus, Entre Plus |
| Viatris Specialty LLC | $24.13 | 2025 | Yupelri |
| Philips North America LLC | $23.53 | 2019 | |
| Advanced Respiratory, INC | $22.67 | 2021 | |
| Portola Pharmaceuticals, LLC | $20.62 | 2019 | |
| Inspire Medical Systems, INC. | $17.82 | 2025 | Inspire |
| Pfizer INC. | $17.70 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.80 | 2024 | Quviviq |
| Resmed Corp | $15.38 | 2024 | |
| Galvanize Therapeutics, INC | $15.15 | 2024 | Aliya System |
| Arbor Pharmaceuticals, INC. | $14.72 | 2021 | |
| Lilly USA, LLC | $14.67 | 2025 | Zepbound |
| Shire North American Group INC | $13.63 | 2019 | |
| Cook Medical LLC | $13.45 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.38 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Panchal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.